Skip to main content
Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
33.66
+0.17 (0.51%)
Feb 27, 2026, 4:00 PM EST - Market closed

Galapagos NV Revenue

In the year 2025, Galapagos NV had annual revenue of 1.11B EUR with 303.50% growth. Galapagos NV had revenue of 900.82M in the quarter ending December 31, 2025, with 1,093.22% growth.

Revenue (ttm)
1.11B EUR
Revenue Growth
+303.50%
P/S Ratio
1.69
Revenue / Employee
1,993,276 EUR
Employees
558
Market Cap
2.21B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.11B836.60M303.50%
Dec 31, 2024275.65M35.93M14.99%
Dec 31, 2023239.72M-1.53M-0.63%
Dec 31, 2022241.25M6.87M2.93%
Dec 31, 2021234.38M-243.67M-50.97%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Telix Pharmaceuticals 803.79M
Ultragenyx Pharmaceutical 673.00M
Zai Lab 460.16M
Stoke Therapeutics 205.63M
Mesoblast 65.38M
Ascentage Pharma Group International 54.52M
Nuvation Bio 26.75M
Immunome 9.68M
Revenue Rankings

GLPG News

More News